loadpatents
Patent applications and USPTO patent grants for FOORD; Orit.The latest application filed is for "methods for selective in vivo expansion of gamma delta t-cell populations and compositions thereof".
Patent | Date |
---|---|
Methods For Selective In Vivo Expansion Of Gamma Delta T-cell Populations And Compositions Thereof App 20220218747 - JAKOBOVITS; Aya ;   et al. | 2022-07-14 |
Engineered Gamma Delta T-cells App 20220160765 - Jakobovits; Aya ;   et al. | 2022-05-26 |
Methods for selective expansion of .gamma..delta. T-cell populations and compositions thereof Grant 11,299,708 - Jakobovits , et al. April 12, 2 | 2022-04-12 |
Engineered .gamma..delta. T-cells Grant 11,135,245 - Jakobovits , et al. October 5, 2 | 2021-10-05 |
Light chain variable regions Grant 11,033,634 - Stull , et al. June 15, 2 | 2021-06-15 |
Anti-PTK7 antibodies and methods of use Grant 10,836,831 - Foord , et al. November 17, 2 | 2020-11-17 |
Antibodies Capable Of Binding Hla-a2/tyrd In An Hla Restricted Manner And Uses Thereof App 20200207858 - Jakobovits; Aya ;   et al. | 2020-07-02 |
Anti Sez6 Antibodies And Methods Of Use App 20200181256 - SAUNDERS; LAURA ;   et al. | 2020-06-11 |
Dll3 Modulators And Methods Of Use App 20200138969 - Stull; Robert A. ;   et al. | 2020-05-07 |
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof App 20200062860 - Weber; Richard F. ;   et al. | 2020-02-27 |
Anti SEZ6 antibodies and methods of use Grant 10,533,051 - Saunders , et al. Ja | 2020-01-14 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof Grant 10,508,153 - Weber , et al. Dec | 2019-12-17 |
Dll3 Modulators And Methods Of Use App 20190247510 - STULL; ROBERT A. ;   et al. | 2019-08-15 |
Methods For Selective Expansion Of Gamma Delta T-cell Populations And Compositions Thereof App 20190119634 - Jakobovits; Aya ;   et al. | 2019-04-25 |
Novel Anti-claudin Antibodies And Methods Of Use App 20190077876 - SANTAGUIDA; Marianne ;   et al. | 2019-03-14 |
Dll3 Modulators And Methods Of Use App 20190046656 - STULL; ROBERT A. ;   et al. | 2019-02-14 |
Anti-DLL3 antibody drug conjugates for treating cancer Grant 10,137,204 - Stull , et al. November 27, 2 | 2018-11-27 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof Grant 10,118,968 - Weber , et al. November 6, 2 | 2018-11-06 |
Anti-CD324 monoclonal antibodies and uses thereof Grant 10,087,258 - Stull , et al. October 2, 2 | 2018-10-02 |
Novel Modulators And Methods Of Use App 20180237512 - HAMPL; JOHANNES ;   et al. | 2018-08-23 |
Anti-claudin antibodies and methods of use Grant 10,053,511 - Santaguida , et al. August 21, 2 | 2018-08-21 |
High affinity human antibodies to human cytomegalovirus (CMV) gB protein Grant 10,030,069 - Kauvar , et al. July 24, 2 | 2018-07-24 |
Novel Modulators And Methods Of Use App 20180162952 - FOORD; ORIT ;   et al. | 2018-06-14 |
Modulators and methods of use Grant 9,969,798 - Hampl , et al. May 15, 2 | 2018-05-15 |
Anti-DLL3 antibody drug conjugates and methods of use Grant 9,937,268 - Stull , et al. April 10, 2 | 2018-04-10 |
Methods of delivering DLL3 antibody drug conjugates Grant 9,931,421 - Stull , et al. April 3, 2 | 2018-04-03 |
Methods of making DLL3 antibody drug conjugates Grant 9,931,420 - Stull , et al. April 3, 2 | 2018-04-03 |
PTK7 modulators and methods of use Grant 9,914,784 - Foord , et al. March 13, 2 | 2018-03-13 |
Methods Of Delivering Dll3 Antibody Drug Conjugates App 20180036422 - STULL; ROBERT A. ;   et al. | 2018-02-08 |
Methods Of Making Dll3 Antibody Drug Conjugates App 20180036421 - STULL; ROBERT A. ;   et al. | 2018-02-08 |
Methods of delivering DLL3 antibody drug conjugates Grant 9,878,053 - Stull , et al. January 30, 2 | 2018-01-30 |
Anti-dll3 Antibody Drug Conjugates And Methods Of Use App 20180015178 - STULL; ROBERT A. ;   et al. | 2018-01-18 |
Anti-DLL3 antibody drug conjugates Grant 9,867,887 - Stull , et al. January 16, 2 | 2018-01-16 |
Kits containing DLL3 antibody drug conjugates Grant 9,861,708 - Stull , et al. January 9, 2 | 2018-01-09 |
Anti-DLL3 antibody drug conjugates Grant 9,855,343 - Stull , et al. January 2, 2 | 2018-01-02 |
Anti-dll3 Antibody Drug Conjugates App 20170368195 - STULL; ROBERT A. ;   et al. | 2017-12-28 |
Anti Sez6 Antibodies And Methods Of Use App 20170369571 - SAUNDERS; LAURA ;   et al. | 2017-12-28 |
Kits Containing Dll3 Antibody Drug Conjugates App 20170307622 - STULL; ROBERT A. ;   et al. | 2017-10-26 |
Anti-DLL3 antibody drug conjugates for treating cancer Grant 9,775,916 - Stull , et al. October 3, 2 | 2017-10-03 |
Dll3 Modulators And Methods Of Use App 20170274094 - STULL; ROBERT A. ;   et al. | 2017-09-28 |
Anti-DLL3 antibody drug conjugates Grant 9,770,518 - Stull , et al. September 26, 2 | 2017-09-26 |
Methods Of Making Dll3 Antibody Drug Conjugates App 20170266314 - STULL; ROBERT A. ;   et al. | 2017-09-21 |
Anti-dll3 Antibody Drug Conjugates App 20170266312 - STULL; ROBERT A. ;   et al. | 2017-09-21 |
Methods Of Delivering Dll3 Antibody Drug Conjugates App 20170266313 - STULL; ROBERT A. ;   et al. | 2017-09-21 |
Anti-dll3 Antibody Drug Conjugates For Treating Cancer App 20170266315 - STULL; ROBERT A. ;   et al. | 2017-09-21 |
Methods of making DLL3 antibody drug conjugates Grant 9,764,042 - Stull , et al. September 19, 2 | 2017-09-19 |
Modulators and methods of use Grant 9,765,136 - Hampl , et al. September 19, 2 | 2017-09-19 |
High Affinity Human Antibodies To Human Cytomegalovirus (cmv) Gb Protein App 20170204165 - KAUVAR; Lawrence M. ;   et al. | 2017-07-20 |
High affinity human antibodies to human cytomegalovirus (CMV) GB protein Grant 9,688,744 - Kauvar , et al. June 27, 2 | 2017-06-27 |
Anti SEZ6 antibodies and methods of use Grant 9,676,850 - Saunders , et al. June 13, 2 | 2017-06-13 |
Anti-cd324 Monoclonal Antibodies And Uses Thereof App 20170121416 - STULL; Robert A. ;   et al. | 2017-05-04 |
Novel Modulators And Methods Of Use App 20170081419 - Dylla; Scott J. ;   et al. | 2017-03-23 |
Dll3 Modulators And Methods Of Use App 20170000901 - STULL; Robert A. ;   et al. | 2017-01-05 |
Anti-CD324 monoclonal antibodies and uses thereof Grant 9,534,058 - Stull , et al. January 3, 2 | 2017-01-03 |
Anti-DLL3 antibody drug conjugates Grant 9,480,757 - Stull , et al. November 1, 2 | 2016-11-01 |
Anti-DLL3 antibody drug conjugates Grant 9,481,727 - Stull , et al. November 1, 2 | 2016-11-01 |
Antibodies Directed To GPNMB And Uses Thereof App 20160311919 - Xiao; Feng ;   et al. | 2016-10-27 |
Novel Anti-claudin Antibodies And Methods Of Use App 20160289332 - SANTAGUIDA; Marianne ;   et al. | 2016-10-06 |
Modulators and methods of use Grant 9,458,231 - Dylla , et al. October 4, 2 | 2016-10-04 |
Novel Modulators And Methods Of Use App 20160272723 - FOORD; ORIT ;   et al. | 2016-09-22 |
Novel Modulators And Methods Of Use App 20160264653 - HAMPL; JOHANNES ;   et al. | 2016-09-15 |
Novel Modulators And Methods Of Use App 20160257745 - HAMPL; JOHANNES ;   et al. | 2016-09-08 |
Anti-DLL3 antibody drug conjugates App 20160250348 - STULL; Robert A. ;   et al. | 2016-09-01 |
Anti-DLL3 antibody drug conjugates App 20160251431 - STULL; Robert A. ;   et al. | 2016-09-01 |
Anti-DLL3 antibody drug conjugates App 20160228571 - STULL; Robert A. ;   et al. | 2016-08-11 |
PTK7 modulators and methods of use Grant 9,409,995 - Foord , et al. August 9, 2 | 2016-08-09 |
Engineered Gamma Delta T-cells App 20160175358 - Jakobovits; Aya ;   et al. | 2016-06-23 |
Kits Containing Dll3 Antibody Drug Conjugates App 20160158379 - Stull; Robert A. ;   et al. | 2016-06-09 |
Methods of making DLL3 antibody drug conjugates Grant 9,358,304 - Stull , et al. June 7, 2 | 2016-06-07 |
Methods Of Delivering Dll3 Antibody Drug Conjugates App 20160151513 - Stull; Robert A. ;   et al. | 2016-06-02 |
Kits containing DLL3 antibody drug conjugates Grant 9,352,051 - Stull , et al. May 31, 2 | 2016-05-31 |
Anti-DLL3 antibodies Grant 9,353,182 - Stull , et al. May 31, 2 | 2016-05-31 |
Methods of delivering DLL3 antibody drug conjugates Grant 9,345,784 - Stull , et al. May 24, 2 | 2016-05-24 |
Methods Of Making Dll3 Antibody Drug Conjugates App 20160136296 - STULL; Robert A. ;   et al. | 2016-05-19 |
Multivalent Dll3 Antibodies App 20160130331 - Stull; Robert A. ;   et al. | 2016-05-12 |
Multivalent DLL3 antibodies Grant 9,334,318 - Stull , et al. May 10, 2 | 2016-05-10 |
Anti-RSV G protein antibodies Grant 9,321,830 - Kauvar , et al. April 26, 2 | 2016-04-26 |
Modulators and methods of use Grant 9,320,812 - Hampl , et al. April 26, 2 | 2016-04-26 |
Antibodies immunoreactive with heregulin-coupled HER3 Grant 9,321,839 - Keyt , et al. April 26, 2 | 2016-04-26 |
Dll3 Modulators And Methods Of Use App 20160075779 - STULL; Robert A. ;   et al. | 2016-03-17 |
Anti-cd324 Monoclonal Antibodies And Uses Thereof App 20150337048 - STULL; Robert A. ;   et al. | 2015-11-26 |
Anti-dll3 Antibody Drug Conjugates App 20150328332 - STULL; ROBERT A. ;   et al. | 2015-11-19 |
Notum Protein Modulators And Methods Of Use App 20150322166 - STULL; Robert A. ;   et al. | 2015-11-12 |
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof App 20150315288 - Weber; Richard F. ;   et al. | 2015-11-05 |
Anti-DLL3 antibody drug conjugates Grant 9,173,959 - Stull , et al. November 3, 2 | 2015-11-03 |
Anti-DLL3 antibody drug conjugates and methods of use Grant 9,155,803 - Stull , et al. October 13, 2 | 2015-10-13 |
Anti-dll3 Antibody Drug Conjugates And Methods Of Use App 20150265724 - Stull; Robert A. ;   et al. | 2015-09-24 |
Anti-DLL3 antibody drug conjugates and methods of use Grant 9,133,271 - Stull , et al. September 15, 2 | 2015-09-15 |
High Affinity Human Antibodies To Human Cytomegalovirus (cmv) Gb Protein App 20150252099 - KAUVAR; Lawrence M. ;   et al. | 2015-09-10 |
Anti-DLL3 antibody drug conjugates for treating cancer Grant 9,107,961 - Stull , et al. August 18, 2 | 2015-08-18 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof Grant 9,096,672 - Weber , et al. August 4, 2 | 2015-08-04 |
Anti-DLL3 antibody drug conjugates and methods of use Grant 9,089,616 - Stull , et al. July 28, 2 | 2015-07-28 |
Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies Grant 9,090,683 - Stull , et al. July 28, 2 | 2015-07-28 |
Anti-DLL3 antibody drug conjugates Grant 9,089,617 - Stull , et al. July 28, 2 | 2015-07-28 |
Anti-DLL3 antibodies Grant 9,089,615 - Stull , et al. July 28, 2 | 2015-07-28 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof Grant 9,085,624 - Weber , et al. July 21, 2 | 2015-07-21 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof Grant 9,073,998 - Weber , et al. July 7, 2 | 2015-07-07 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof Grant 9,062,113 - Weber , et al. June 23, 2 | 2015-06-23 |
High affinity human antibodies to human cytomegalovirus (CMV) gB protein Grant 9,017,668 - Kauvar , et al. April 28, 2 | 2015-04-28 |
Nucleic acid encoding DLL3 antibodies Grant 8,986,972 - Stull , et al. March 24, 2 | 2015-03-24 |
Antibodies Directed to GPNMB and Uses Thereof App 20150044212 - Xiao; Feng ;   et al. | 2015-02-12 |
Anti Sez6 Antibodies And Methods Of Use App 20150018531 - Saunders; Laura ;   et al. | 2015-01-15 |
Antibodies Immunoreactive With Heregulin-coupled Her3 App 20140370548 - KEYT; Bruce ;   et al. | 2014-12-18 |
Dll3 Modulators And Methods Of Use App 20140370037 - STULL; ROBERT A. ;   et al. | 2014-12-18 |
Dll3 Modulators And Methods Of Use App 20140364593 - STULL; ROBERT A. ;   et al. | 2014-12-11 |
Dll3 Modulators And Methods Of Use App 20140363826 - STULL; ROBERT A. ;   et al. | 2014-12-11 |
Dll3 Modulators And Methods Of Use App 20140363887 - STULL; ROBERT A. ;   et al. | 2014-12-11 |
Dll3 Modulators And Methods Of Use App 20140364590 - STULL; ROBERT A. ;   et al. | 2014-12-11 |
Dll3 Modulators And Methods Of Use App 20140363455 - STULL; ROBERT A ;   et al. | 2014-12-11 |
Novel Modulators And Methods Of Use App 20140302034 - Bankovich; Alex ;   et al. | 2014-10-09 |
Antibodies directed to GPNMB and uses thereof Grant 8,846,873 - Xiao , et al. September 30, 2 | 2014-09-30 |
Heparin-binding epidermal growth factor-like growth factor binding proteins Grant 8,828,382 - Rothe , et al. September 9, 2 | 2014-09-09 |
Antibodies immunoreactive with heregulin-coupled HER3 Grant 8,828,388 - Keyt , et al. September 9, 2 | 2014-09-09 |
High Affinity Fully Human Monoclonal Antibodies To Interleukin-8 And Epitopes For Such Antibodies App 20140105905 - Babcook; John ;   et al. | 2014-04-17 |
Novel Modulators And Methods Of Use App 20140105888 - Foord; Orit ;   et al. | 2014-04-17 |
Novel Modulators And Methods Of Use App 20140093495 - Hampl; Johannes ;   et al. | 2014-04-03 |
High affinity fully human monoclonal antibodies to interleukin-8 Grant 8,604,174 - Babcook , et al. December 10, 2 | 2013-12-10 |
Novel Modulators And Methods Of Use App 20130302355 - Dylla; Scott J. ;   et al. | 2013-11-14 |
Notum Protein Modulators And Methods Of Use App 20130224191 - Stull; Robert A. ;   et al. | 2013-08-29 |
Antibodies Immunoreactive With Heregulin-coupled Her3 App 20130122000 - KEYT; Bruce ;   et al. | 2013-05-16 |
Novel Modulators and Methods of Use App 20130058947 - Stull; Robert A. ;   et al. | 2013-03-07 |
Anti-rsv G Protein Antibodies App 20130034564 - KAUVAR; Lawrence M. ;   et al. | 2013-02-07 |
Antibodies immunoreactive with heregulin-coupled HER3 Grant 8,362,215 - Keyt , et al. January 29, 2 | 2013-01-29 |
Antibodies Directed To GPNMB And Uses Thereof App 20130022597 - Xiao; Feng ;   et al. | 2013-01-24 |
Anti-RSV G protein antibodies Grant 8,273,354 - Kauvar , et al. September 25, 2 | 2012-09-25 |
High Affinity Human Antibodies To Human Cytomegalovirus (cmv) Gb Protein App 20120020980 - KAUVAR; LAWRENCE M. ;   et al. | 2012-01-26 |
Antibodies directed to tumor necrosis factor and uses thereof Grant 8,101,178 - Babcook , et al. January 24, 2 | 2012-01-24 |
Fully human monoclonal antibodies to IL-13 Grant 7,994,302 - Foltz , et al. August 9, 2 | 2011-08-09 |
Antibodies against interleukin-1 .beta. Grant 7,964,193 - Green , et al. June 21, 2 | 2011-06-21 |
Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins App 20110110956 - Rothe; Mike ;   et al. | 2011-05-12 |
Antibodies Immunoreactive With Heregulin-coupled Her3 App 20100310557 - KEYT; Bruce ;   et al. | 2010-12-09 |
Anti-rsv G Protein Antibodies App 20100285022 - KAUVAR; Lawrence M. ;   et al. | 2010-11-11 |
Antibodies against interleukin-1 beta App 20100183616 - Green; Larry ;   et al. | 2010-07-22 |
Anti-RSV G protein antibodies Grant 7,736,648 - Kauvar , et al. June 15, 2 | 2010-06-15 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof Grant 7,736,644 - Weber , et al. June 15, 2 | 2010-06-15 |
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof App 20100111979 - WEBER; RICHARD ;   et al. | 2010-05-06 |
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof Grant 7,687,606 - Gudas , et al. March 30, 2 | 2010-03-30 |
Fully Human Monoclonal Antibodies To Il-13 App 20100047253 - Foltz; Ian ;   et al. | 2010-02-25 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof Grant 7,628,986 - Weber , et al. December 8, 2 | 2009-12-08 |
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof App 20090240038 - Weber; Richard ;   et al. | 2009-09-24 |
Fully human monoclonal antibodies to IL-13 Grant 7,585,500 - Foltz , et al. September 8, 2 | 2009-09-08 |
Antibodies against interleukin-1.beta. Grant 7,566,772 - Green , et al. July 28, 2 | 2009-07-28 |
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof App 20090175887 - Weber; Richard ;   et al. | 2009-07-09 |
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof App 20090155282 - Weber; Richard ;   et al. | 2009-06-18 |
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof App 20090156790 - Weber; Richard ;   et al. | 2009-06-18 |
High Affinity Fully Human Monoclonal Antibodies To Interleukin-8 And Epitopes For Such Antibodies App 20090130110 - Babcook; John ;   et al. | 2009-05-21 |
Anti-rsv G Protein Antibodies App 20090130120 - KAUVAR; Lawrence M. ;   et al. | 2009-05-21 |
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof Grant 7,482,434 - Gudas , et al. January 27, 2 | 2009-01-27 |
Antibodies Directed To Tumor Necrosis Factor And Uses Thereof App 20080187531 - Babcook; John S. ;   et al. | 2008-08-07 |
Antibodies directed to tumor necrosis factor Grant 7,285,269 - Babcook , et al. October 23, 2 | 2007-10-23 |
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof App 20070128112 - Gudas; Jean M. ;   et al. | 2007-06-07 |
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof App 20070116708 - Gudas; Jean M. ;   et al. | 2007-05-24 |
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof Grant 7,202,343 - Gudas , et al. April 10, 2 | 2007-04-10 |
Antibodies against interleukin-1 beta App 20070065439 - Green; Larry ;   et al. | 2007-03-22 |
Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders App 20060286112 - Kellermann; Sirid-Aimee ;   et al. | 2006-12-21 |
Fully human monoclonal antibodies to IL-13 App 20060140948 - Foltz; Ian ;   et al. | 2006-06-29 |
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof App 20050058639 - Gudas, Jean M. ;   et al. | 2005-03-17 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof App 20050059087 - Weber, Richard ;   et al. | 2005-03-17 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof App 20050053608 - Weber, Richard ;   et al. | 2005-03-10 |
Antibodies directed to tumor necrosis factor and uses thereof App 20050049402 - Babcook, John S. ;   et al. | 2005-03-03 |
Generation Of Modified Molecules With Increased Serum Half-lives App 20020142374 - GALLO, MICHAEL ;   et al. | 2002-10-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.